1. Home
  2. TROX vs SNDX Comparison

TROX vs SNDX Comparison

Compare TROX & SNDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TROX
  • SNDX
  • Stock Information
  • Founded
  • TROX N/A
  • SNDX 2005
  • Country
  • TROX United States
  • SNDX United States
  • Employees
  • TROX N/A
  • SNDX N/A
  • Industry
  • TROX Major Chemicals
  • SNDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TROX Industrials
  • SNDX Health Care
  • Exchange
  • TROX Nasdaq
  • SNDX Nasdaq
  • Market Cap
  • TROX 1.7B
  • SNDX 1.6B
  • IPO Year
  • TROX 2005
  • SNDX 2016
  • Fundamental
  • Price
  • TROX $11.00
  • SNDX $15.83
  • Analyst Decision
  • TROX Strong Buy
  • SNDX Strong Buy
  • Analyst Count
  • TROX 5
  • SNDX 11
  • Target Price
  • TROX $18.00
  • SNDX $36.00
  • AVG Volume (30 Days)
  • TROX 1.2M
  • SNDX 1.7M
  • Earning Date
  • TROX 10-24-2024
  • SNDX 11-05-2024
  • Dividend Yield
  • TROX 4.53%
  • SNDX N/A
  • EPS Growth
  • TROX N/A
  • SNDX N/A
  • EPS
  • TROX 0.27
  • SNDX N/A
  • Revenue
  • TROX $3,084,000,000.00
  • SNDX $16,000,000.00
  • Revenue This Year
  • TROX $11.09
  • SNDX N/A
  • Revenue Next Year
  • TROX $3.44
  • SNDX $219.92
  • P/E Ratio
  • TROX $41.53
  • SNDX N/A
  • Revenue Growth
  • TROX 9.63
  • SNDX N/A
  • 52 Week Low
  • TROX $10.69
  • SNDX $14.81
  • 52 Week High
  • TROX $20.70
  • SNDX $25.34
  • Technical
  • Relative Strength Index (RSI)
  • TROX 30.75
  • SNDX 32.96
  • Support Level
  • TROX $10.69
  • SNDX $16.03
  • Resistance Level
  • TROX $13.14
  • SNDX $17.87
  • Average True Range (ATR)
  • TROX 0.39
  • SNDX 0.93
  • MACD
  • TROX -0.13
  • SNDX -0.45
  • Stochastic Oscillator
  • TROX 13.06
  • SNDX 1.26

About TROX Tronox Holdings plc (UK)

Tronox Holdings PLC is a vertically integrated manufacturer of TiO2 pigment. It operates titanium-bearing mineral sand mines and beneficiation and smelting operations in Australia & South Africa to produce feedstock materials that can be processed into TiO2 for pigment, high-purity titanium chemicals, including titanium tetrachloride, and ultrafine TiO2 used in certain specialty applications. TiO2 and titanium feedstock, are used to produce paints and coatings, as well as plastics, paper, and printing ink. It has three pigment production facilities in the United States, the Netherlands, and Western Australia and three mining operations in Western Australia and South Africa. North America, Asia-Pacific and Europe the Middle East, and Africa regions contribute the vast majority of revenue.

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

Share on Social Networks: